REGISTER HERE!

DESCRIPTION

This year’s program is designed to specifically focus on the latest and most exciting advances in the management of heart failure through a series of didactic lectures, case presentations and debates. Topics that will be covered extend from preventing heart failure by managing risk factors such as hypertension, diabetes and hyperlipidemia to treating heart failure throughout all its stages.

Key areas that will be covered include management of sleep disordered breathing, use of biomarkers, treatment of pulmonary artery hypertension, new uses of DOACs, HFpEF, management of atrial fibrillation, prevention of sudden death and integration of both older and newer heart failure drugs into the therapeutic regimen. The Symposium also covers use of percutaneous mechanical circulatory support and LVADs, heart transplantation as well as new treatment options for amyloid cardiomyopathy.

There will be in-depth discussion about the rationale for and practical aspects of using new drugs for treating activation of the renin angiotensin system, slowing heart rate and managing hyperkalemia. In addition to the formal presentations, we have expanded opportunities for interactive discussions between the speakers and the audience in the program.

SYMPOSIUM OBJECTIVES

At the conclusion of this program, the participant should be able to:
1. Summarize current and emerging treatments for heart failure, describe new
guideline updates and provide practical information to help in the implementation
of recommended therapies in individual patients.
2. Review strategies for implementing medical and device therapies that will
enhance prevention and lead to improved outcomes in heart failure patients.
3. Define how specific populations including minorities, women and the elderly
respond to various approaches to treating hypertension and heart failure.

TARGET AUDIENCE

The target audience for this activity includes cardiologists, internists, primary
care physicians, nurses and allied healthcare professionals.